Akari Therapeutics Plc (AKTX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch AKTX
See up to 3 months of AKTX. The 7-day demo opens the 1M and 3M ranges and puts AKTX on your watchlist.
Start 7-day demoLatest AKTX insider trades
About Akari Therapeutics Plc (AKTX)
Akari Therapeutics Plc files with the SEC under CIK 0001541157 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector. The registration was withdrawn on 21 May 2026, so the planned offering is not going ahead in its filed form.
AKTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 9,288 | |
| Option exercise | 6 | 44,948 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AKTX insider transactions (Form 4)
6928 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Abizer Gaslightwala - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 6,430 footnote F1 | $9.72 | $62K | |
| ||||||
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 1,728 footnote F1 | $7.52 | $13K | |
| ||||||
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 1,130 footnote F1 | $11.50 | $13K | |
| ||||||
| Samir Rashmikant Patel - Director | Option exercise | American Depositary Shares representing Ordinary Shares | 1,209 | $8.00 | $10K | |
| Samir Rashmikant Patel - Director | Option exercise | American Depositary Shares representing Ordinary Shares | 15,466 | $0.00 | $6 | |
| Samir Rashmikant Patel - Director | Option exercise | American Depositary Shares representing Ordinary Shares | 5,799 | $0.00 | $2 | |
| Samir Rashmikant Patel - Director | Option exercise | Pre-Funded Warrant to purchase American Depositary Shares | 1,209 | $32.00 | $39K | |
| Samir Rashmikant Patel - Director | Option exercise | Pre-Funded Warrant to purchase ADSs | 15,466 | $16.16 footnote F4 | $250K | |
| Samir Rashmikant Patel - Director | Option exercise | Pre-Funded Warrant to purchase ADSs | 5,799 | $16.16 footnote F5 | $94K | |
| ||||||
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 2,539 footnote F1 | $5.12 | $13K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 3,725 footnote F1 | $3.49 | $13K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 7,353 footnote F1 | $3.74 | $28K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 1,000 footnote F1 | $13.00 | $13K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 1,248 footnote F1 | $10.02 | $13K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 1,395 footnote F1 | $9.32 | $13K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 1,570 footnote F1 | $8.28 | $13K | |
| ||||||
| Abizer Gaslightwala - Officer | Grant or award | Stock Option (Right to Buy) | 15,563 | $0.00 | - | |
| Abizer Gaslightwala - Officer | Grant or award | Stock Option (Right to Buy) | 5,500 | $0.00 | - | |
| James R. Neal - Director | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 2,473 | - footnote F4 | - | |
| James R. Neal - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 2,473 | $0.40 footnote F4 | $999 | |
| James R. Neal - Director | Open-market purchase | Warrants to purchase ADRs | 3,093 | - footnote F5 | - | |
| James R. Neal - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 3,093 | $0.40 footnote F5 | $1K | |
| ||||||
| Raymond Prudo-Chlebosz - Director | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 618,658 | - | - | |
| Raymond Prudo-Chlebosz - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 618,658 | $0.40 | $250K | |
| Raymond Prudo-Chlebosz - Director | Open-market purchase | Warrants to purchase ADRs | 386,661 | - | - | |
| Raymond Prudo-Chlebosz - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 386,661 | $0.40 | $156K | |
| Sandip I. Patel - Director | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 247,462 | - | - | |
| Sandip I. Patel - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 247,462 | $0.40 | $100K | |
| Sandip I. Patel - Director | Open-market purchase | Warrants to purchase ADRs | 154,664 | - | - | |
| Sandip I. Patel - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 154,664 | $0.40 | $62K | |
| Hoyoung Huh - Director | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 618,658 | - | - | |
| Hoyoung Huh - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 618,658 | $0.40 | $250K | |
| Hoyoung Huh - Director | Open-market purchase | Warrants to purchase ADRs | 3,093,293 | - | - | |
| Hoyoung Huh - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 3,093,293 | $0.40 | $1.25M | |
| Kameel D. Farag - Officer | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 24,745 | - | - | |
| Kameel D. Farag - Officer | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 24,745 | $0.40 | $10K | |
| Samir Rashmikant Patel - Director | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 618,658 | - | - | |
| Samir Rashmikant Patel - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 618,658 | $0.40 | $250K | |
| Samir Rashmikant Patel - Director | Open-market purchase | Warrants to purchase ADRs | 231,997 | - | - | |
| Samir Rashmikant Patel - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 231,997 | $0.40 | $94K | |
| Abizer Gaslightwala - Officer | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 309,328 | - | - | |
| Abizer Gaslightwala - Officer | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 309,328 | $0.40 | $125K | |
| Abizer Gaslightwala - Officer | Open-market purchase | Warrants to purchase ADRs | 773,323 | - | - | |
| Abizer Gaslightwala - Officer | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 773,323 | $0.40 | $312K | |
| Robert B. Bazemore - Director | Open-market purchase | Warrants to purchase American Depositary Shares ("ADRs") | 123,731 | - | - | |
| Robert B. Bazemore - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 123,731 | $0.40 | $50K | |
| Robert B. Bazemore - Director | Open-market purchase | Warrants to purchase ADRs | 30,932 | - | - | |
| Robert B. Bazemore - Director | Open-market purchase | Pre-Funded Warrants to purchase ADRs | 30,932 | $0.40 | $12K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 26,619 footnote F3 | $0.75 | $20K | |
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 32,000 footnote F2 | $0.75 | $24K | |
| ||||||
| Kameel D. Farag - Officer | Grant or award | American Depositary Shares representing Ordinary Shares | 6,277 footnote F2 | $0.74 | $5K | |
| ||||||
| Abizer Gaslightwala - Officer | Open-market purchase | American Depositary Shares representing Ordinary Shares | 10,000 | $0.94 | $9K | |
| Abizer Gaslightwala - Officer | Open-market purchase | American Depositary Shares representing Ordinary Shares | 8,000 | $0.93 | $7K | |
| Abizer Gaslightwala - Officer | Open-market purchase | American Depositary Shares representing Ordinary Shares | 3,000 | $0.90 | $3K | |
| Samir Rashmikant Patel | Grant or award | Ordinary Shares, par value $0.0001 per share | 3,200,000 | $0.00 | $2K | |
| Samir Rashmikant Patel | Grant or award | Ordinary Shares, par value $0.0001 per share | 400,000 | $0.00 | $200 | |
| Abizer Gaslightwala | Grant or award | Ordinary Shares, par value $0.0001 per share | 40,000,000 | $0.00 | $20K | |
| Abizer Gaslightwala | Grant or award | Ordinary Shares, par value $0.0001 per share | 30,000,000 | $0.00 | $15K | |
| Samir Rashmikant Patel | Grant or award | Ordinary Shares, par value $0.0001 per share | 7,500,000 | $0.00 | $4K | |
| James R. Neal | Grant or award | Ordinary Shares, par value $0.0001 per share | 2,000,000 | $0.00 | $1K | |
| Samir Rashmikant Patel | Grant or award | Ordinary Shares, par value $0.0001 per share | 1,400,000 | $0.00 | $700 | |
| Samir Rashmikant Patel | Grant or award | Ordinary Shares, par value $0.0001 per share | 419,286,000 | $0.00 | $503K | |
| Samir Rashmikant Patel | Grant or award | Stock Option (Right to Buy) | 162,604,000 | $0.00 | - | |
| Samir Rashmikant Patel | Grant or award | Warrants (Right to Buy) | 419,286,000 | $0.00 | $503K | |
| Raymond Prudo-Chlebosz | Grant or award | Ordinary Shares, par value $0.0001 per share | 419,286,000 | $0.00 | $503K | |
| Raymond Prudo-Chlebosz | Grant or award | Warrants (Right to Buy) | 419,286,000 | $0.00 | $503K | |
| Samir Rashmikant Patel | Grant or award | Ordinary Shares, par value $0.0001 per share | 1,404,622,000 | - | - | |
| Samir Rashmikant Patel | Grant or award | Stock Option (Right to Buy) | 79,684,000 | $0.00 | - | |
| Samir Rashmikant Patel | Grant or award | Stock Option (Right to Buy) | 175,080,000 | $0.00 | - | |
Item 5.02, 9.01
Item 2.02, 9.01
Item 5.07, 9.01
Item 1.01, 9.01
AKTX insider trading FAQ
What is the latest insider trade for AKTX?
Akari Therapeutics Plc (AKTX) had 4 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for AKTX runs to 28 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AKTX stock?
No insider purchases of AKTX were filed in the last 90 days. 33 purchases are on record for this company.
How many insiders are selling AKTX stock?
No insider sales of AKTX were filed in the last 90 days.
Where can I see AKTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AKTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Abizer Gaslightwala view on EDGAR
- - Kameel D. Farag view on EDGAR
- - Kameel D. Farag view on EDGAR
- - Samir Rashmikant Patel view on EDGAR
- - Kameel D. Farag view on EDGAR
- - Abizer Gaslightwala view on EDGAR
- - James R. Neal view on EDGAR
- - Raymond Prudo-Chlebosz view on EDGAR
- - Sandip I. Patel view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AKTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AKTX with a 7-day demo
- AKTX on your watchlist
- Every AKTX Form 4 filing on record
- Up to 3 months of AKTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
